skip to main content
Rising Medical Inflation in Asia Pacific

It is estimated that by 2020, the global middle class will reach 3.2 billion and swell to 4.9 billion in 2030, by which time Asia will represent a staggering 66 percent of the global middle-class population. 

The growth in urbanisation and middle class affluence has been characterised by the adoption of sedentary lifestyles which, in turn, has created an epidemic of chronic diseases including cardiovascular, cerebrovascular, diabetes and cancer-related illnesses.

Asia has transitioned from a medical profile of communicable disease to non-communicable (NCD) in nature requiring investment into clinics, hospitals, diagnostic facilities and pharmaceutical manufacturing. This will prove challenging to medical inflation due to increasing utilization and the escalating cost of medical technology. 

With the evidence that modifiable lifestyle behaviours are driving the NCD epidemic, a rethink on how to establish Employee Health and Well-being programs is required. 



Disclaimer - This content is brought to you by Chubb Insurance Malaysia Berhad (“Chubb”) as a convenience to readers and is not intended to constitute advice or recommendations upon which a reader may rely. Chubb makes no warranty or guarantee about the accuracy, completeness, or adequacy of this content. It is the responsibility of the reader to evaluate the quality and accuracy of material herein.

Download the full infographic

Rising Medical Inflation in Asia Pacific

Related Articles

Have a question or need more information?

Contact us to find out how we can help you get covered against potential risks